Last reviewed · How we verify
NCT04074694: JRP
Treatment of Juvenile Recurrent Parotitis: the Yield of Minimally Invasive Intervention
NA trial testing Sialoendoscopy in Parotitis, Juvenile Recurrent in 30 participants. Status unknown.
1 January 2023
Quick facts
| Lead sponsor | Carmel Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 January 2020 |
| Primary completion | 1 January 2023 |
| Estimated completion | 1 January 2023 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Sialoendoscopy
Conditions studied
- Parotitis, Juvenile Recurrent — all drugs for Parotitis, Juvenile Recurrent →
Sponsor
Carmel Medical Center
Who can join
Adults 3 to 18, any sex, with Parotitis, Juvenile Recurrent. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Juvenile recurrent parotitis (JRP) is an inflammatory disease characterized by recurrent painful swelling of the Parotid gland in the pediatric age. A watchful waiting treatment strategy was acceptable for most children; however, recent studies claimed that a sialoendoscopic intervention may stop the recurrent flare-ups. The Objective of our study: To determine the effectiveness of sialoendoscopy vs. conservative therapy ('watch and wait') alone for Juvenile Recurrent Parotitis Research Endpoints: The study's endpoints will evaluate frequency and severity of flare-ups before and after treatment and Quality of Life parameters as evaluated according to life-quality questionnaires.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04074694
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Carmel Medical Center trials
Trials by the same sponsor.
- NCT06604455 — Impact of Acupuncture and Integrative Medicine on Patients Quality-of-life During National Emergency and Wartime · NA · recruiting
- NCT06612749 — Assessing the Impact of Integrative Medicine on Anxiety and Wellbeing of Healthcare Providers Exposed to Terror or War · NA · recruiting
- NCT06598020 — Evaluating the Impact of an Integrative Oncology Training Program for Healthcare Providers · NA · active not recruiting
- NCT06590766 — Impact of Acupuncture and Manual Therapies on Patients' Quality-of-life in a Hospital-to-community Continuum · NA · recruiting
- NCT06167057 — POST URS Chemotherapy Instillation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04074694 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Carmel Medical Center
- Last refreshed: 30 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04074694.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing